393970.Kq
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
Business. The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Commodity Chemicals industry, producing and selling chemical products, primarily generating revenue through the sale of these goods to industrial and manufacturing customers.
The company's capital structure is heavily leveraged, with a debt-to-equity ratio of 1.35, indicating a significant reliance on debt financing. Liquidity is constrained, as evidenced by a current ratio of 0.76 and a negative free cash flow of -55.34 billion KRW, which suggests the company is not generating sufficient cash to cover its operating and capital expenditures. The price-to-book ratio of 0.8 and price-to-tangible-book ratio of 0.8 indicate that the company's market value is below its book value, potentially signaling undervaluation or financial distress.
Profitability is severely underperforming, with a net loss of -38.29 billion KRW and an operating loss of -21.32 billion KRW. Return on equity is -73.06%, and return on assets is -25.2%, both of which are well below the typical performance metrics for the Commodity Chemicals industry. The company's gross profit of 1.21 billion KRW is minimal relative to its revenue of 84.51 billion KRW, indicating high production costs or low pricing power.
The company's revenue is concentrated in a single business segment, as no segment breakdown is provided in the available data. There is no indication of geographic diversification, and the company's exposure to regional markets is not disclosed. This lack of diversification could increase vulnerability to regional economic downturns or supply chain disruptions.
The company's growth trajectory is negative, with a net loss and declining cash flow. No specific revenue growth or decline percentages are provided in the available data, but the operating and free cash flow figures suggest a deteriorating financial position. The company's capital expenditures of -21.44 billion KRW indicate ongoing investment, but the negative sign suggests these expenditures are not being offset by revenue growth.
The company faces medium liquidity risk, as its cash and equivalents of 2.85 billion KRW are insufficient to cover its total liabilities of 99.51 billion KRW. The risk assessment also flags a negative net cash position after subtracting total debt, which could limit the company's ability to meet short-term obligations. Dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding.
No recent events, such as filings or transcripts, are provided in the available data to inform the company's current strategic or operational developments.
- The company is experiencing significant financial distress, with a net loss and negative operating and free cash flows.
- The company's capital structure is highly leveraged, with a debt-to-equity ratio of 1.35.
- Profitability metrics are severely underperforming, with a negative return on equity and return on assets.
- The company's liquidity is constrained, with a current ratio of 0.76 and insufficient cash to cover liabilities.
- There is no indication of geographic or segment diversification, increasing vulnerability to regional or sector-specific risks.
- Dilution risk is low, but the company's financial position may limit its ability to raise capital without issuing new shares.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- 393970.KQ Market data — financials · 2026-05-26